Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents (2020)
Fonte: RSC Medicinal Chemistry. Unidade: IFSC
Assuntos: TRYPANOSOMA CRUZI, LEISHMANIA INFANTUM, PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOOVITS, Paul J. et al. Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents. RSC Medicinal Chemistry, v. No 2020, n. 11, p. 1267-1274, 2020Tradução . . Disponível em: https://doi.org/10.1039/d0md00165a. Acesso em: 02 out. 2024.APA
Koovits, P. J., Dessoy, M. A., Matheeussen, A., Maes, L., Caljon, G., Ferreira, L. L. G., et al. (2020). Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents. RSC Medicinal Chemistry, No 2020( 11), 1267-1274. doi:10.1039/d0md00165aNLM
Koovits PJ, Dessoy MA, Matheeussen A, Maes L, Caljon G, Ferreira LLG, Chelucci RC, Duarte SM, Andricopulo AD, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents [Internet]. RSC Medicinal Chemistry. 2020 ; No 2020( 11): 1267-1274.[citado 2024 out. 02 ] Available from: https://doi.org/10.1039/d0md00165aVancouver
Koovits PJ, Dessoy MA, Matheeussen A, Maes L, Caljon G, Ferreira LLG, Chelucci RC, Duarte SM, Andricopulo AD, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents [Internet]. RSC Medicinal Chemistry. 2020 ; No 2020( 11): 1267-1274.[citado 2024 out. 02 ] Available from: https://doi.org/10.1039/d0md00165a